Clinical trial
Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus…
NCT00497237 · Chiesi Farmaceutici S.p.A., Industry · Completed
Key facts
| NCT number | NCT00497237 |
|---|---|
| Title | Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma |
| Official title | Prospective, Randomised, Open-label, Multicentre, Active Drug Controlled, Parallel Group Design Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate 400 mcg + Formoterol 24 mcg pMDI Via HFA-134a (Foster™) vs. Fluticasone Propionate 500 mcg + Salmeterol Xinafoate 100 mcg DPI… |
| Acronym | FORTE |
| Lead sponsor | Chiesi Farmaceutici S.p.A., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Beclomethasone plus formoterol fixed combination, Fluticasone plus salmeterol fixed combination |
| Enrollment | 382 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jul 6, 2007 |
| Last update posted | Mar 30, 2017 |
| Countries | Bulgaria, Italy, Ukraine |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: